Aug 4, 2026
When schools closed in the spring of 2020 at the onset of the COVID-19 pandemic, the number of children and adolescents receiving mental health treatment in the United States fell by more than half. By 2022, that number had exceeded pre-pandemic levels.
Jul 7, 2026
Beat Childhood Cancer has announced the implementation of the WeTrials AI-powered patient engagement platform to help families discover, understand and engage with pediatric cancer clinical research opportunities across the consortium’s study portfolio.
Jun 25, 2026
Plants have always played an integral role in traditional medicine and healing practices, according to Kent Vrana, Elliot S. Vesell Professor of Pharmacology at Penn State College of Medicine, and they continue to shape health and medicine today.
Jun 12, 2026
Just four minutes of daily strengthening exercise dramatically increases key factors in quality of life for aging adults, according to a new study led by researchers at Penn State College of Medicine.
Jun 3, 2026
Artificial intelligence (AI)-powered chatbots respond to everyday health-related questions from general users with nearly 76% accuracy, which raises concerns about their trustworthiness in real-world client-facing applications, according to a new study led by Penn State researchers.
May 26, 2026
Penn State College of Medicine researchers have discovered that a DNA repair protein gene gone rogue may unlock new cancer treatments.
May 21, 2026
A new study led by researchers from Penn State College of Medicine found that switching to a pod-based salt-nicotine e-cigarette could improve the odds of quitting cigarette smoking while meaningfully lowering exposure to harmful chemicals.
Apr 23, 2026
Penn State College of Medicine has launched a new wave of interdisciplinary research through its inaugural Research Momentum Team Grants.
Apr 15, 2026
Three students from Penn State College of Medicine are among the 42 recipients across the University recognized through the Graduate Student Awards.
A new clinical trial led by the Penn State College of Medicine-based Beat Childhood Cancer Research Consortium will evaluate whether the drug eflornithine (DFMO) can help prevent relapse and improve outcomes for patients with Ewing sarcoma and osteosarcoma.
